Ibrahim, M., El-Raey, F., Fathy, N., & El-Bakrey, K. (2020). Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients. Al-Azhar University, Faculty of Medicine (Damietta).
Cita Chicago Style (17a ed.)Ibrahim, Magda, Fathiya El-Raey, Naglaa Fathy, y Kadrey El-Bakrey. Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients. Al-Azhar University, Faculty of Medicine (Damietta), 2020.
Cita MLA (8a ed.)Ibrahim, Magda, et al. Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients. Al-Azhar University, Faculty of Medicine (Damietta), 2020.
Precaución: Estas citas no son 100% exactas.